Background: The ventral anterior limb of the internal capsule (vALIC) is a target for deep brain
(NAc), and contains dopaminergic projections from the VTA to the VS [9] . The supero-lateral branch of the MFB has been described as a DBS target for treatment-resistant depression (TRD) [10] and more recently for OCD [11] , where DBS could potentially be effective through improvement of the patient's mood. On the other hand, the ATR connects the PFC to the anterior thalamus and is part of the cortico-striatal-thalamo-cortical (CSTC) network, which is dysregulated in OCD [12] .
In this study, we used DWI data to determine whether vALIC DBS for OCD can benefit from specific targeting of the ATR or MFB, which could enable the optimization of DBS targeting and advance our understanding of OCD's pathophysiology. We used tractography to reconstruct the ATR and MFB, and associated the distance between these bundles and the active DBS contacts with treatment response.
Material and Methods

Patients
The data for this study were collected retrospectively from patients who were routinely treated at the Academic Medical Center (AMC) in Amsterdam, The Netherlands. Data were retrieved from electronic databases and fully anonymized. Inclusion requirements for this study were the availability of a pre-operative DWI scan suitable for tractography analysis, and a Yale-Brown obsessivecompulsive scale (Y-BOCS) assessment at baseline and after 12 months of DBS. All patients were screened according to regular DBS in-and exclusion criteria for OCD, as described by Denys and colleagues [13] . In brief, patients between 18-65 years of age, diagnosed with primary OCD for at least 5 years with a minimum baseline Y-BOCS score of 28 were eligible for DBS if the following treatments were unsuccessful: two sessions with a selective serotonin reuptake inhibitor (SSRI) at maximum dosage for 12 weeks, one session of clomipramine for 12 weeks, one augmentation trial with an atypical anti-psychotic and an SSRI for 8 weeks, and at least 16 sessions of cognitivebehavioral therapy (CBT). Exclusion criteria were significant comorbid DSM-IV Axis I disorders (except major depressive disorder (MDD) and mild anxiety disorders), severe DSM-IV Axis II personality M A N U S C R I P T A C C E P T E D 
DBS surgery
3T MRI scans were made to assess surgical eligibility at baseline. On the morning of surgery, a stereotactic frame was attached to the patient's head under general anesthesia, before scanning the patient in a 1.5T MRI scanner. Surgical planning was performed according to standard stereotactic procedures described in detail by Van den Munckhof and colleagues [5] . In short, the 3T scan and stereotactic 1.5T scan were co-registered with SurgiPlan (Elekta AB, Stockholm, Sweden) to enable planning in the stereotactic space. Target 
DBS treatment
The DBS device was activated two weeks after implantation, with the two middle electrode contact points (contacts 1 and 2) bilaterally activated at 3.5V, 130 Hz, 90 μs, double unipolar stimulation. This marked the start of the optimization phase, during which the voltage was increased stepwise and clinically evaluated (bi)weekly. In the case of insufficient response after increasing the voltage, other (combinations of) electrode contact points were activated, and the process was repeated. For some patients, the stimulation's pulse width and frequency were altered with the aim of reducing side effects (e.g., agitation) or increasing the therapeutic effect. The duration of the optimization phase varied a lot between patients and lasted approximately 6 months on average. After the optimization phase, the stimulation parameters were kept constant and the patients received CBT.
Since we know from prior work that symptoms reduce further after CBT [13, 14] , we opted to evaluate treatment outcome when stimulation settings were stable and (the majority of) patients had received a least one course of CBT of approximately 24 weeks. Based on these criteria and the availability of 12 months follow-up data, we chose the Y-BOCS score obtained 12 months after surgery to evaluate treatment efficacy. The treatment response in our sample ranged between a 70%
decrease and a 20% increase in Y-BOCS scores (see Table 1 ). While some patients classified as nonresponders appeared to be partial responders with a Y-BOCS score decrease of up to 33%, others did not experience any symptom improvement at all. Due to the fluctuating nature of OCD symptom scores, it may not be surprising that one of the patients even had a higher Y-BOCS score after starting DBS treatment.
We used 3T structural MRI and DWI data to reconstruct the ATR and MFB, and merged the results with the post-operative computed tomography scan that visualizes the DBS electrode position. The distance from the active stimulation site relative to the ATR and the MFB was computed, and associated with the change in the Y-BOCS score due to DBS treatment. We also compared the anatomical locations of stimulation in standard space without DWI to ascertain that treatment response is bundle dependent.
All scans were routinely made according to clinical protocols. The 3T scans were made at baseline parameters between diffusion and structural space were calculated with ANTS symmetric diffeomorphic image registration [16] . Since CT scans are not spatially distorted, the CT scans were co-registered to the structural MRI scans via a rigid transformation (ANTS), after the non-brain parts of the CT scan were removed with a custom Matlab 2014b (The Mathworks, Natick, MA) script.
Individual tractography seed ROIs were drawn in the ATR and MFB in the anterior thalamic nucleus and ventral tegmental area respectively, based on Coenen et al. (2012) . Additional waypoint seeds were drawn in the vALIC. All seeds were drawn in structural space and transformed to diffusion space prior to tractography.
Diffusion preprocessing and tractography
Diffusion preprocessing consisted of correcting for eddy currents and motion artifacts by affinely coregistering all diffusion-weighted volumes to the b 0 reference volume with FSL. The orientation of the b-vectors was updated accordingly [17] . Subsequently, the data were noise filtered with an adaptive LMSSE-filter that was implemented in Matlab [18] . To ensure data uniformity in the subsequent stages of analysis and because most tracking algorithms perform better with isotropic voxel sizes [19, 20] , the data were resampled into an isotropic 2 mm resolution. Finally, voxelwise diffusion orientation estimates were extracted with FSL's Bedpostx [21] . Probabilistic tractography was carried out with FSL's probtrackx, with the aforementioned seeds. Tracking parameters were mostly default (5000 samples; curve threshold = 0.2; max. steps = 2500; 0.5 mm step length). The tracking results
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9 were visually inspected before and after transformation to structural space to ensure that there were no systematic differences between the two diffusion acquisitions.
Distance calculation and group level analysis
In order to preserve the individual spatial relationship between bundles and electrodes, tractography results were analyzed in subject space. Since all electrodes were identical, we performed group level analyses in a common space centered around the electrode as described below. Using this procedure, we maintained the neuroimaging data in subject space, while the analyses were performed in the common 'electrode-space'. This is schematically depicted in Figure 2 . All electrodes are oriented approximately along the inferior-superior direction within the brain, so that the axial slices centered around the electrodes can be related to a fixed depth along the electrode ( Figure 2B ).
Aligning these slices while preserving the transversal orientations enabled a direct comparison of tractography results between subjects.
We calculated the relative distance from the electrode to the MFB and ATR to determine which bundle was closer to the active stimulation. The relative distance was defined as , where signifies the left-right average. The individual distances between the electrode and the bundles and were calculated between the active contact and the closest part of the bundle ( Figure 2C ). All distances were computed based on normalized and thresholded tract probability maps. The threshold level was heuristically set to 18%, at which value the distribution of distances over subjects between contacts and bundles was optimal. Note that the relative distance is relatively invariant to this threshold level. The distances between the active contact points and the thresholded bundles were calculated in 3D with a custom Matlab script using the distance transform from the dip image toolbox (version 2.4.1, http://www.diplib.org/). Since subjects were stimulated at more than one contact, the shortest distance was chosen for the analysis.
Statistical analysis
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We calculated Pearson's correlation between the relative distances and the percentage change in Y-BOCS score to investigate their possible relationship. To correct for possible effects of using two different DWI acquisition types, we additionally performed linear regression with the sequence type as covariate.
Stimulation site heat map
To assess whether the anatomical positioning of DBS electrodes was different between responders and non-responders, we performed an additional analysis without using the information provided by DWI. We generated a heat map of treatment (non-)responders by combining the previously identified active contact sites of all patients in MNI-space (Montreal Neurological Institute), based on nonlinear transformation parameters that were calculated between each individual's T1-scan and a brain template with ANTS. In this way, it was possible to assess whether differences in treatment outcome depend on stimulation location with respect to anatomical landmarks, or bundle trajectories alone.
Results
Group level results: distance from bundles to active contacts
We first identified the ATR and supero-lateral branch of the MFB in both hemispheres for all subjects and located their positions with respect to the implanted electrodes. According to surgical planning, the electrode tips were located ventrally to the WM bundles in the NAc and the active contacts were located within the vALIC. For most subjects, there was a distinct medial-lateral organization of, respectively, the ATR and MFB within the vALIC. The electrodes were targeted to pass through the lateral part of the vALIC, which for most subjects coincided with a more proximate MFB. Next, we were not due to outliers, we conducted a non-parametric Spearman's rank correlation. This analysis has reduced power, but still returned a correlation at trend level (r= 0.54, p=0.07). The results are illustrated in Figure 3 . For illustration, axial and coronal views of the tractography around the electrodes' active stimulation depth for a responder and non-responder are shown in Figure 4 . The responder is stimulated closer to the MFB than the ATR, and vice-versa for the non-responder. A complete overview of axial slices of all patients ordered by treatment response is shown in Figure 5 .
Stimulation heat map
To determine whether treatment responders and non-responders could also be distinguished without knowledge of white matter bundle orientations, we created a heat map of active contact point positions in standard anatomical space, which is shown in Figure 6 . There is a large overlap within and between groups, with all stimulation sites in approximately the same location within the vALIC. This indicates that the anatomical location of the DBS electrodes does not differentiate treatment responders from non-responders.
Discussion
The aim of this study was to determine whether vALIC DBS for OCD could benefit from specific targeting of the supero-lateral branch of the MFB or ATR. We performed fiber tractography to investigate the potential relationship between bundle trajectories and stimulation sites. Through comparison of distances from the active contacts to both bundles for all patients, we found that stimulation closer to the MFB is significantly correlated with better treatment response, while there was no apparent relationship between treatment response and location of stimulation with respect to anatomical landmarks. These results may be relevant for future DBS surgical planning and targeting in OCD, but they may also help elucidating underlying mechanisms of DBS for OCD.
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Our main finding suggests that targeting the MFB would be beneficial to improve treatment efficacy, even though stimulation may reach beyond the MFB. DBS specifically targeted at the MFB has already gained some interest as therapy for TRD [22] , whereas specific targeting of the MFB for OCD is in its infancy [11] . Based on this study it is not possible to determine the optimal location to stimulate the supero-lateral branch of the MFB. The patients described in this study received DBS in the vALIC based on anatomical landmarks, and as such are not directly comparable to patients receiving MFB-specific DBS near the VTA. Further research is necessary to determine the efficacy of MFB-targeted DBS in the vALIC as opposed to near the VTA, although the use of tractographyinformed stimulation in both anatomical locations seems warranted.
Considering the prevalence of comorbid depression in treatment-resistant OCD patients [13, 23] , it is possible that stimulation of the MFB initiates a therapeutic effect in OCD through an improvement in mood similar to MFB DBS for TRD. This is supported by clinical observations that suggest that DBS initially improves mood and anxiety [24] , in advance of long-term recovery of compulsive symptoms through CBT [13, 14] . Within OCD pathophysiology, it would seem that the MFB is mainly responsible for the depressed mood and anxiety associated with obsessions, and stimulation of the MFB would indirectly increase the patients' ability to cope with and challenge compulsive behavior. Nonetheless, our results do not provide evidence on whether pathological MFB connectivity is responsible for OCD in the first place, or that the improvement in mood and anxiety due to MFB stimulation merely acts as a catalyst for CBT targeted at compulsivity, since we have not looked into the effect of stimulation and CBT separately.
The limited role of the ATR in the efficacy of DBS for OCD could be considered surprising, as the ATR connects different brain structures within the CSTC network that are at the core of the pathophysiological model of OCD [25] . The more prominent role for the MFB supports more recent models of OCD that acknowledge the importance of additional affective networks [12, 26, 27] .
Nevertheless, these networks may interact at the level of the striatum, as the MFB connects the M A N U S C R I P T
A C C E P T E D ACCEPTED MANUSCRIPT
13 striatum, PFC and VTA. Therefore, the MFB could influence the CSTC at different locations within the network, which may be necessary to enable normalization of CSTC activity for these otherwise refractory patients [4, 28] .
Limitations of this work include the small number of subjects (N=12). Even though statistical power was sufficient to detect associations between white matter trajectories and clinical outcome, small sample sizes limit the generalizability of the results. In order to avoid the potential influence of outliers in our small sample, we conducted a non-parametric Spearman's rank correlation. This correlation coefficient was highly comparable to the parametric Pearson's correlation but the significance level was slightly lower, which we attribute to the lower statistical power in nonparametric vs. parametric tests. Our sample was considerable given the limited number of patients that underwent DBS for OCD and completed pre-surgical DWI scanning. Regardless, future studies should aim to replicate these results with more subjects.
A second limitation is the use of two different diffusion sequences that originated from an update in clinical scanning protocols over the inclusion period. After correction for sequence differences (by including a covariate for the different sequence types) the results remained significant (p=0.02),
indicating that the results are robust with respect to sequence type. Another limitation lies within the use of tractography. Tractography is a powerful tool that can be used to optimize existing targeting procedures [29] , or provide a rationale for hitherto untested DBS targets [10] . However, one must take care when interpreting tracking results, since tractography is not an exact reconstruction of WM pathways and trajectories may vary with the tracking algorithm's parameters.
Furthermore, diffusion-weighted scans are susceptible to imaging artifacts and results may be dependent on the quality of data (pre-)processing. To minimize the influence of these factors, we used robust preprocessing strategies and probabilistic tractography [30] .
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Future work should focus on prospective testing of MFB-targeted stimulation by incorporating tractography information into surgical planning and DBS optimization, which may increase treatment response and shorten the time to optimize stimulation settings.
Conclusions
In this retrospective study, we have shown that active stimulation of the vALIC closer to the superolateral branch of the MFB than the ATR is related to a better outcome for treatment-refractory OCD.
It is possible that stimulation of the affective circuitry is responsible for this treatment effect, similar to antidepressant effects of MFB DBS for TRD. Tractography-assisted targeting of the MFB inside the vALIC could lead to improved treatment response, which needs to be tested in a prospective study.
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